Phreesia (NYSE: PHR) revenue
Phreesia reported revenue of $480.6m for fiscal 2026, 14.5% more than in fiscal 2025 ($419.8m). Since fiscal 2019 its revenue has grown by 381.1%, an average growth of 25.2% a year.
Phreesia has grown its revenue for 7 years in a row, and fiscal 2026 is the highest of its 8 fiscal years on record.
Embed this chart
Copy this code into your website or blog. The chart updates with each new annual report.
Revenue by fiscal year
| Fiscal year | Revenue | Change | Operating profit | Operating margin |
|---|---|---|---|---|
| 2026 | $480.6m | +14.5% | −$6.6m | −1.4% |
| 2025 | $419.8m | +17.8% | −$58.1m | −13.8% |
| 2024 | $356.3m | +26.8% | −$136.5m | −38.3% |
| 2023 | $280.9m | +31.7% | −$176.6m | −62.9% |
| 2022 | $213.2m | +43.4% | −$116.8m | −54.8% |
| 2021 | $148.7m | +19.1% | −$25.7m | −17.3% |
| 2020 | $124.8m | +24.9% | −$15.3m | −12.3% |
| 2019 | $99.9m | — | −$9.5m | −9.5% |
The change compares each fiscal year with the one before. Operating margin is operating profit over revenue from the same filing. Figures are in millions of US dollars, except per-share amounts.
Phreesia revenue compared with its sector
By revenue for its latest fiscal year, Phreesia ranks 196th of the 422 US health care companies with a page on Celsmar. The sector median grew 11.7% in its latest fiscal year; Phreesia, 14.5%.
| Rank | Company | Revenue | Revenue growth |
|---|---|---|---|
| 194th | BridgeBio Pharma | $502.1m | 126.3% |
| 195th | Travere Therapeutics | $490.7m | 110.5% |
| 196th | Phreesia | $480.6m | 14.5% |
| 197th | Zai Lab | $460.2m | 15.3% |
| 198th | Tarsus Pharmaceuticals | $451.4m | 146.7% |
Each amount is in the currency the company reports in; the rank converts them to US dollars at the 16 November 2026 exchange rate. The rest are in US health care stocks.
Questions about the revenue of Phreesia
- How much revenue did Phreesia make in fiscal 2026?
- Phreesia reported revenue of $480.6m for fiscal 2026, compared with $419.8m in fiscal 2025.
- How much has the revenue of Phreesia grown?
- Between fiscal 2019 and fiscal 2026 it went from $99.9m to $480.6m: 381.1% more, an average growth of 25.2% a year.
- What was the best year for revenue at Phreesia?
- Of its last 8 fiscal years, fiscal 2026, with $480.6m.
- Where does Phreesia rank in its sector by revenue?
- It ranks 196th of the 422 US health care companies with a page on Celsmar, by revenue for its latest fiscal year.
- Where do the figures for Phreesia come from?
- From the annual report (Form 10-K) that Phreesia files with the SEC, the US securities regulator. Each fiscal year links to its filing.
Where each figure comes from
From the annual report (Form 10-K) that Phreesia files with the SEC. The filing for each fiscal year: 2026 · 2025 · 2024 · 2023 · 2022 · 2021 · 2020 · 2019. More on Phreesia: the Phreesia page · annual accounts · net income · insider transactions.
Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.